Breast cancer treatment and research at Dana-Farber
More than 175,000 cases of invasive breast cancer and 62,000 cases of in situ breast cancer are expected to be diagnosed in the U.S. in 2007, according to the American Cancer Society (ACS). The ACS projects that more than 40,000 breast cancer patients will die from the disease this year.
Dana-Farber's Gillette Center for Women's Cancers has created a patient-focused, multidisciplinary care program designed to ensure the best possible quality of life during and following treatment, while also fostering innovative research to advance the understanding, prevention, early detection, and treatment of breast cancer.
Related Links
- Treatment for Breast Cancer at Dana-Farber
- The Friends of Dana-Farber Cancer Risk and Prevention Clinic
- DFCI Clinical Trials
- Cancer and the Family
Related Stories
- Network approach yields discovery of a potential breast cancer susceptibility gene (October 11, 2007)
- Combined screening approach leads to discovery of gene linked to breast cancer (June 14, 2007)
- Dana-Farber's Eric Winer, MD, named chief scientific advisor of Susan G. Komen for the Cure (May 23, 2007)
- International study points to new breast cancer-susceptibility gene (Feb. 9. 2007)
- Molecular atlas provides new tool for understanding estrogen-fueled breast cancer (October 2, 2006)
- Women's Cancers Program leaders spur new breast cancer consortium (Spring/Summer 2006)
- Advances in chemotherapy improve outcomes in select breast cancers (April 12, 2006)
- New cellular flaw found in some virulent breast cancers (January 17, 2006)
- Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer (Dec. 8, 2005)
- New project explores genetic and emotional sides of metastatic breast cancer (Fall/Winter 2005)
- Breast Cancer Program leads the way in integrating services at DFCI, BWH (Fall/Winter 2005)
- Dana-Farber/Brigham and Women's Cancer Center team to demonstrate multidisciplinary treatment for breast cancer during Webcast (Oct. 26, 2005)
- Herceptin treatment lowers recurrence rate in early breast cancer (Oct. 19, 2005)
- Subtle changes in normal genes implicated in breast cancer (July 14, 2005)
- Woman, interrupted: Enhancing care for young women with breast cancer (Spring 2005)
- Breast cancer's outside agitators (Spring 2005)
- Test predicts risk of blood clot in women receiving tamoxifen therapy for breast cancer (May 17, 2005)
- Breast tumor's biological traits guide hormone therapy (May 17, 2005)
- Moderate alcohol use linked to increase in breast cancer risk (May 16, 2005)
- How often should women get mammograms? (Feb. 22, 2005)
- Study helps doctors identify childhood cancer survivors at increased risk of developing breast cancer (Oct. 18, 2004)
- Dana-Farber, Brigham and Women's researchers study role of diet and exercise in breast cancer risk and recovery (Oct. 4, 2004)
- Study suggests broader chemotherapy attack in breast cancer (July 19, 2004)
- North America's largest-ever breast cancer prevention trial nears enrollment goal of 19,000 patients (April 13, 2004)
- BRCA mutations not associated with colorectal cancer risk, studies suggest (Jan. 7, 2004)
- Study supports tailoring adjuvant therapy for early-stage breast cancer (Jan. 5, 2004)

